Boston Scientific U.S. — Net Sales decreased by 3.0% to $3.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.9%, from $2.96B to $3.28B. Over 4 years (FY 2021 to FY 2025), U.S. — Net Sales shows an upward trend with a 16.8% CAGR.
bsx_segment_u_s_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.80B | $1.73B | $1.80B | $1.78B | $1.93B | $1.93B | $1.99B | $2.00B | $2.11B | $2.10B | $2.21B | $2.26B | $2.47B | $2.59B | $2.89B | $2.96B | $3.22B | $3.29B | $3.39B | $3.28B |
| QoQ Change | — | -4.1% | +4.2% | -1.2% | +8.7% | +0.1% | +2.7% | +0.8% | +5.3% | -0.5% | +5.4% | +2.0% | +9.2% | +5.2% | +11.6% | +2.3% | +8.9% | +2.2% | +2.8% | -3.0% |
| YoY Change | — | — | — | — | +7.4% | +12.1% | +10.5% | +12.7% | +9.2% | +8.5% | +11.4% | +12.7% | +16.9% | +23.5% | +30.7% | +31.1% | +30.7% | +27.0% | +17.0% | +10.9% |